Asia-Pacific Sleep-Wake Disorder Market
Asia-Pacific Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Industry Overview
Asia-Pacific sleep-wake disorder market was valued at $5.1 billion in 2025 and is projected to reach $9.5 billion by 2035, growing at a CAGR of 6.3% from 2026 to 2035. The Asia-Pacific sleep-wake disorder market is witnessing steady expansion owing to the increasing adoption of advanced diagnostic technologies across healthcare facilities and sleep clinics. Rising work-related stress, irregular lifestyles, and prolonged screen exposure have contributed to a higher demand for clinical evaluation and long-term sleep management solutions. In addition, healthcare providers across countries such as Japan, China, India, and Australia are strengthening access to specialized treatment services and home-based monitoring systems. Growing awareness regarding the impact of untreated sleep conditions on cardiovascular, neurological, and mental health outcomes is further supporting market development. Technological progress in wearable sleep tracking devices and non-invasive therapeutic equipment is also improving patient engagement and treatment adherence across the region.
Market Dynamics
Expansion of Home-Based Sleep Monitoring Solutions
The Asia-Pacific sleep-wake disorder market is experiencing increased demand for home-based diagnostic and monitoring technologies due to the growing preference for convenient and cost-effective care models. Healthcare providers are gradually integrating portable sleep assessment devices and remote patient monitoring platforms to improve accessibility in both urban and semi-urban regions. The adoption of connected wearable technologies is also supporting continuous sleep pattern analysis and long-term patient management. In addition, digital healthcare infrastructure improvements across several Asia-Pacific countries are encouraging the use of teleconsultation and cloud-based sleep data systems. This trend is contributing to earlier diagnosis and more consistent treatment follow-up among patients with chronic sleep-related conditions.
Rising Investment in Advanced Therapeutic Technologies
Manufacturers and healthcare organizations across the Asia-Pacific region are increasingly focusing on the development of technologically advanced therapeutic solutions for sleep-wake disorders. Companies are introducing non-invasive respiratory support systems, smart sleep devices, and AI-supported diagnostic platforms to improve clinical efficiency and patient outcomes. The expansion of sleep clinics and specialty care centers in countries such as China, Japan, South Korea, and India is also strengthening the availability of specialized treatment services. Furthermore, increasing collaboration between healthcare institutions and medical technology providers is supporting innovation in personalized sleep management approaches. These developments are enhancing treatment adoption rates and contributing to the long-term growth of the regional market.
Market Segmentation
- Based on the disorder type, the market is segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm sleep-wake disorders, parasomnias, dyssomnias, and others.
- Based on the treatment type, the market is segmented into pharmacological therapy, behavioral therapy, light therapy, device-based therapy, and others.
- Based on the diagnosis & management approach, the market is segmented into polysomnography & sleep studies, actigraphy-based monitoring, clinical evaluation & screening tools, and remote/digital sleep monitoring solutions.
- Based on the application, the market is segmented into hospitals, home care settings, and others.
Sleep Apnea Segment to Lead the Market with the Largest Share
The sleep apnea segment is witnessing notable expansion due to the rising number of patients affected by obesity, respiratory complications, and age-related sleep disturbances across both developed and emerging economies. Healthcare providers are increasingly recommending early diagnostic screening and long-term respiratory support therapies to reduce complications associated with untreated conditions. Companies such as ResMed Inc. and Fisher & Paykel Healthcare Corporation Limited are focusing on technologically advanced airflow devices and patient-friendly mask systems to improve treatment compliance. Market participants are also introducing connected sleep therapy equipment integrated with cloud-based monitoring capabilities for remote patient management. The growing use of portable diagnostic systems and home-based treatment approaches is further supporting segment growth across healthcare settings.
Device-Based Therapy: A Key Segment in Market Growth
The device-based therapy segment is gaining considerable attention as healthcare institutions increasingly adopt non-invasive treatment technologies for long-term sleep disorder management. Demand for advanced therapeutic equipment has increased due to the growing preference for continuous monitoring, automated pressure adjustment systems, and improved patient comfort features. Manufacturers, including Koninklijke Philips N.V. and Compumedics Limited, are expanding their product portfolios with digitally integrated sleep management solutions. Recent developments in wearable respiratory support systems and AI-assisted therapy optimization tools are also contributing to stronger clinical outcomes. In addition, rising investment in sleep laboratories and home care treatment infrastructure is creating favorable conditions for continued segment expansion.
Regional Outlook
The Asia-Pacific sleep-wake disorder market is further divided by countries, including India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of the Asia-Pacific.
China Dominates the Market with a Major Share
China continues to maintain a leading position in the Asia-Pacific sleep-wake disorder market due to the rapid expansion of sleep clinics, rising healthcare expenditure, and increasing awareness regarding untreated sleep conditions. Urban lifestyle changes, demanding work schedules, and growing stress-related health concerns have contributed to a higher demand for diagnostic and therapeutic solutions across the country. Companies such as BMC Medical Co. Ltd. and ResMed Inc. are strengthening their regional presence through advanced respiratory support technologies and digital sleep monitoring platforms. Recent market activity reflects stronger adoption of portable sleep testing systems and home-based therapy devices across metropolitan healthcare networks. In addition, government efforts to modernize hospital infrastructure and expand digital healthcare accessibility are supporting long-term market expansion in China.
Market Players Outlook
The major companies operating in the Asia-Pacific sleep-wake disorder market include ResMed Inc., Fisher & Paykel Healthcare Corp. Ltd., Takeda Pharmaceutical Company Ltd., Compumedics Ltd., and Nihon Kohden Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In November 2025, Koninklijke Philips N.V. partnered with MedAdvisor in Australia to improve public access to sleep health support through pharmacy networks. The initiative focused on identifying individuals at risk of obstructive sleep apnea and expanding awareness regarding diagnosis and treatment pathways using pharmacy-led digital engagement systems.
- In September 2025, Compumedics Limited received FDA clearance for Somfit-D, a single-use home sleep monitoring device designed for sleep-related breathing disorder diagnosis. The company confirmed that the device is cleared across Australia, New Zealand, the European Union, and the United States, supporting broader commercialization opportunities in Asia-Pacific home sleep testing markets.
- In July 2025, Compumedics Limited signed two major four-year distribution agreements in China worth approximately A$24 million to strengthen its sleep diagnostics business across Northern and Eastern China. The expansion focused specifically on sleep and neurology diagnostic technologies, reflecting rising demand for advanced sleep testing infrastructure in Asia-Pacific healthcare systems.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the Asia-Pacific sleep-wake disorder market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Asia-Pacific Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application ($ Million)
- Sleep-Wake Disorder Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Sleep-Wake Disorder Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Sleep-Wake Disorder Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Asia-Pacific Sleep-Wake Disorder Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Asia-Pacific Sleep-Wake Disorder Market: Impact Analysis
- Market Opportunities
- Opportunities For Asia-Pacific Sleep-Wake Disorder Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Sleep-Wake Disorder Market Revenue and Share by Manufacturers
- Sleep-Wake Disorder Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Compumedics Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Fisher & Paykel Healthcare Corp. Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Nihon Kohden Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- ResMed Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Takeda Pharmaceutical Company Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Compumedics Ltd.
- Key Company Analysis
- Asia-Pacific Sleep-Wake Disorder Market Sales Analysis by Disorder Type ($ Million)
- Insomnia
- Hypersomnia
- Sleep Apnea
- Circadian Rhythm Sleep-Wake Disorders
- Parasomnias
- Dyssomnias
- Others
- Asia-Pacific Sleep-Wake Disorder Market Sales Analysis by Treatment Type ($ Million)
- Pharmacological Therapy
- Behavioral Therapy
- Light Therapy
- Device-Based Therapy
- Others
- Asia-Pacific Sleep-Wake Disorder Market Sales Analysis by Diagnosis & Management Approach ($ Million)
- Polysomnography & Sleep Studies
- Actigraphy-Based Monitoring
- Clinical Evaluation & Screening Tools
- Remote / Digital Sleep Monitoring Solutions
- Asia-Pacific Sleep-Wake Disorder Market Sales Analysis by Application ($ Million)
- Hospitals
- Home Care Settings
- Others
- Regional Analysis
- Asia-Pacific Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, and Others)
- Rest of Asia-Pacific
- Company Profiles
- Astellas Pharma Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aurobindo Pharma Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BMC Medical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cadwell Industries Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Compumedics Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Reddy’s Laboratories Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eisai Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fisher & Paykel Healthcare Corp. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GlaxoSmithKline plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Harmony Biosciences Holdings Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jazz Pharmaceuticals plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co. Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Natus Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nihon Kohden Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Otsuka Holdings Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ResMed Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SomnoMed Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sumitomo Pharma Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takeda Pharmaceutical Company Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Astellas Pharma Inc.
1. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
2. Asia-Pacific Insomnia Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
3. Asia-Pacific Hypersomnia Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
4. Asia-Pacific Sleep Apnea Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
5. Asia-Pacific Circadian Rhythm Sleep-Wake Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
6. Asia-Pacific Parasomnias Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
7. Asia-Pacific Dyssomnias Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
8. Asia-Pacific Other Sleep-Wake Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
9. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
10. Asia-Pacific Sleep-Wake Disorder by Pharmacological Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
11. Asia-Pacific Sleep-Wake Disorder by Behavioral Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
12. Asia-Pacific Sleep-Wake Disorder by Light Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
13. Asia-Pacific Sleep-Wake Disorder by Device-Based Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
14. Asia-Pacific Sleep-Wake Disorder by Other Treatment Type Market Research and Analysis by Region, 2025-2035 ($ Million)
15. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
16. Asia-Pacific Polysomnography & Sleep Studies Market Research and Analysis by Region, 2025-2035 ($ Million)
17. Asia-Pacific Actigraphy-Based Monitoring Market Research and Analysis by Region, 2025-2035 ($ Million)
18. Asia-Pacific Clinical Evaluation & Screening Tools Market Research and Analysis by Region, 2025-2035 ($ Million)
19. Asia-Pacific Remote / Digital Sleep Monitoring Solutions Market Research and Analysis by Region, 2025-2035 ($ Million)
20. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
21. Asia-Pacific Sleep-Wake Disorder for Hospitals Market Research and Analysis by Region, 2025-2035 ($ Million)
22. Asia-Pacific Sleep-Wake Disorder for Home Care Settings Market Research and Analysis by Region, 2025-2035 ($ Million)
23. Asia-Pacific Sleep-Wake Disorder for Other Application Market Research and Analysis by Region, 2025-2035 ($ Million)
24. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Geography, 2025-2035 ($ Million)
25. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Country, 2025-2035 ($ Million)
26. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
27. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
28. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
29. Asia-Pacific Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
1. Asia-Pacific Sleep-Wake Disorder Market Share by Disorder Type, 2025 Vs 2035 (%)
2. Asia-Pacific Insomnia Disorder Market Share by Region, 2025 Vs 2035 (%)
3. Asia-Pacific Hypersomnia Disorder Market Share by Region, 2025 Vs 2035 (%)
4. Asia-Pacific Sleep Apnea Disorder Market Share by Region, 2025 Vs 2035 (%)
5. Asia-Pacific Circadian Rhythm Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
6. Asia-Pacific Parasomnias Disorder Market Share by Region, 2025 Vs 2035 (%)
7. Asia-Pacific Dyssomnias Disorder Market Share by Region, 2025 Vs 2035 (%)
8. Asia-Pacific Other Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
9. Asia-Pacific Sleep-Wake Disorder Market Share by Treatment Type, 2025 Vs 2035 (%)
10. Asia-Pacific Sleep-Wake Disorder by Pharmacological Therapy Market Share by Region, 2025 Vs 2035 (%)
11. Asia-Pacific Sleep-Wake Disorder by Behavioral Therapy Market Share by Region, 2025 Vs 2035 (%)
12. Asia-Pacific Sleep-Wake Disorder by Light Therapy Market Share by Region, 2025 Vs 2035 (%)
13. Asia-Pacific Sleep-Wake Disorder by Device-Based Therapy Market Share by Region, 2025 Vs 2035 (%)
14. Asia-Pacific Sleep-Wake Disorder by Other Treatment Type Market Share by Region, 2025 Vs 2035 (%)
15. Asia-Pacific Sleep-Wake Disorder Market Share by Diagnosis & Management Approach, 2025 Vs 2035 (%)
16. Asia-Pacific Polysomnography & Sleep Studies Market Share by Region, 2025 Vs 2035 (%)
17. Asia-Pacific Actigraphy-Based Monitoring Market Share by Region, 2025 Vs 2035 (%)
18. Asia-Pacific Clinical Evaluation & Screening Tools Market Share by Region, 2025 Vs 2035 (%)
19. Asia-Pacific Remote / Digital Sleep Monitoring Solutions Market Share by Region, 2025 Vs 2035 (%)
20. Asia-Pacific Sleep-Wake Disorder Market Share by Application, 2025 Vs 2035 (%)
21. Asia-Pacific Sleep-Wake Disorder for Hospitals Market Share by Region, 2025 Vs 2035 (%)
22. Asia-Pacific Sleep-Wake Disorder for Home Care Settings Market Share by Region, 2025 Vs 2035 (%)
23. Asia-Pacific Sleep-Wake Disorder for Other Application Market Share by Region, 2025 Vs 2035 (%)
24. Asia-Pacific Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
25. India Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
26. China Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
27. Japan Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
28. South Korea Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
29. ASEAN Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
30. Australia and New Zealand Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
31. Rest Of Asia-Pacific Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
